Sampling and analytical procedures:
Bioassay experiments were conducted at station 1 and stations 3. At each station, inorganic and organic phosphate amendments were performed on seawater with and without nitrogen enrichment (NH4Cl, NaNO3). Bioassay Experiments consisted in incubating, over an incubation period of 48h, surface seawater (5m) with inorganic or organic phosphate compounds (20 µM; final concentration of P) including, polyphosphate (polyp), inorganic phosphate (Pi), nucleotides (ATP or AMP) and methylphosphonate (Mepn). In each incubation experiment, a control treatment (surface seawater without amendment) was included.
In bioassay experiments, the bioavailability factor (BF) was determined at T0 for polyphosphate, nucleotides (ATP or AMP) and methylphosphonate (Mepn). BF is calculated as follows: BF=TE-TN/ TP-TN (Björkman and Karl, 1994), where TE reflects PO43- turnover time in the DOP amended treatment, TN is the PO43- turnover time in the control (no additions) and TP is the PO43- turnover time in the treatment amended with Pi. BF ranges from 0 for an unavailable substrate, to a value of 1 for a DOP model substrate having a bioavailability equal to that of +Pi.
Instrument: Radioactivity was assayed on a Packard Tri-Carb liquid scintillation counter.
Location: Northwestern Atlantic surface waters. Depth: surface-50 m.